0001415889-24-010825.txt : 20240415
0001415889-24-010825.hdr.sgml : 20240415
20240415190332
ACCESSION NUMBER: 0001415889-24-010825
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240411
FILED AS OF DATE: 20240415
DATE AS OF CHANGE: 20240415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heyman Richard A.
CENTRAL INDEX KEY: 0001584759
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 24845781
MAIL ADDRESS:
STREET 1: 5871 OBERLIN DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enliven Therapeutics, Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811523849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-647-8519
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: IMARA Inc.
DATE OF NAME CHANGE: 20160419
4
1
form4-04152024_110425.xml
X0508
4
2024-04-11
0001672619
Enliven Therapeutics, Inc.
ELVN
0001584759
Heyman Richard A.
C/O ENLIVEN THERAPEUTICS, INC.
6200 LOOKOUT ROAD
BOULDER
CO
80301
true
false
false
false
1
Common Stock
2024-04-11
4
S
0
5045
25.0306
D
138.425
D
Common Stock
2024-04-15
4
S
0
1190
19.9403
D
137235
D
Common Stock
2024-04-15
4
S
0
80
20.6773
D
137155
D
Common Stock
2024-04-11
4
S
0
649
25
D
28567
I
See footnote
Common Stock
37407
I
See footnote
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023.
This transaction was executed in multiple trades at prices ranging from $25.00 to $25.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $19.61 to $20.5558. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $20.64 to $20.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
The shares are held of record by RAHD Capital LLC for which the Reporting Person serves as a managing member.
The shares are held of record by the Richard A. Heyman and Anne E. Daigle Trust, dated November 1, 2016 for which the Reporting Person serves as trustee.
/s/ Ben Hohl, by power of attorney
2024-04-15